Reaction
Medical Device Change reporting signals
As of the last recalculation, Medical Device Change appears in 528 FAERS reports alongside 12 co-occurring drug terms. The strongest observed disproportionality signal is EPOPROSTENOL (PRR 196.1).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Epoprostenol | 58 | 196.1 | 197.0 |
| Carbidopa And Levodopa | 67 | 63.6 | 63.7 |
| Etonogestrel And Ethinyl Estradiol | 19 | 35.0 | 35.0 |
| Rasagiline Mesylate | 6 | 21.5 | 21.5 |
| Rivastigmine | 10 | 21.3 | 21.3 |
| Baricitinib | 5 | 20.6 | 20.6 |
| Macitentan | 29 | 17.4 | 17.4 |
| Cannabidiol | 10 | 17.2 | 17.2 |
| Bosentan | 20 | 16.2 | 16.2 |
| Pimavanserin Tartrate | 20 | 14.8 | 14.8 |
| Sevoflurane | 3 | 14.3 | 14.3 |
| Droxidopa | 3 | 5.5 | 5.5 |